Literature DB >> 35262789

PTH Spikes During Surgical Treatment for Secondary and Tertiary Hyperparathyroidism: A Prospective Observational Study.

Andre Albuquerque Silveira1,2, Marilia D'Elboux Guimaraes Brescia3, Climerio Pereira do Nascimento3, Felipe Ferraz Magnabosco3, Sergio Samir Arap3, Fabio Luiz de Menezes Montenegro3.   

Abstract

BACKGROUND: The aim of the present study was to determine whether PTH spikes in renal hyperparathyroidism can interfere with the interpretation of intraoperative PTH monitoring and to determine its frequency and characteristics.
METHODS: This was a prospective observational study of consecutive patients who underwent surgical treatment in a single tertiary institution. Patients were divided into two groups: spike and no spike. Patients with secondary and tertiary hyperparathyroidism were analyzed separately. Intraoperative PTH monitoring by venous serial samples: two samples were taken before the excision of the parathyroid gland, and two others were taken after resection.
RESULTS: PTH spikes occurred in 23.5% (53 of 226), and their occurrence was similar between secondary and tertiary hyperparathyroidism patients (p = 0.074). The relative PTH spike intensity was higher in transplanted patients than in dialysis patients (55 vs. 20%, p = 0.029). A characteristic of the secondary hyperparathyroidism patients was the highest frequency of surgical failure (23 vs. 7.5%, p = 0.016) and the higher occurrence of supernumerary glands in the spike group (23 vs. 10.3%, p = 0.035). Supernumerary parathyroid was associated with surgical failure [19.1 (6.5-55.7) odds ratio [confidence interval], p < 0.001). In the studies evaluating the diagnostic test validity for patients on dialysis and experiencing spikes, the most significant impacts were in the sensitivity, accuracy, and negative predictive value of the method.
CONCLUSIONS: PTH spikes occurred in up to 23.5% of renal hyperparathyroidism surgical treatments and can negatively influence the intraoperative parathyroid hormone monitoring. Regarding the phenomenon of PTH spikes, it is prudent to think about the possibility of a hyperplastic supernumerary gland.
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35262789     DOI: 10.1007/s00268-022-06506-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  31 in total

1.  Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism--a consecutive series of 80 patients.

Authors:  J Lokey; F Pattou; A Mondragon-Sanchez; M Minuto; B Mullineris; F Wambergue; P Foissac-Geroux; C Noel; H L de Sagazan; P VanHille; C A Proye
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

2.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

3.  A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism.

Authors:  Marcin Barczyński; Stanisław Cichoń; Aleksander Konturek; Wojciech Cichoń
Journal:  Langenbecks Arch Surg       Date:  2005-02-15       Impact factor: 3.445

4.  The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.

Authors:  Silke V Haustein; Eberhard Mack; James R Starling; Herbert Chen
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

5.  Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism.

Authors:  Daniel Seehofer; Nada Rayes; Jochen Klupp; Thomas Steinmüller; Frank Ulrich; Christian Müller; Ralph Schindler; Ulrich Frei; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2005-02-22       Impact factor: 3.445

6.  Immunochemical heterogeneity of parathyroid hormone in plasma.

Authors:  S A Berson; R S Yalow
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

7.  Critical analysis of the intraoperative parathyroid hormone decrease during parathyroidectomy for secondary and tertiary hyperparathyroidism.

Authors:  Andre Albuquerque Silveira; Marilia D'Elboux Guimaraes Brescia; Climerio Pereira do Nascimento; Sergio Samir Arap; Fabio Luiz de Menezes Montenegro
Journal:  Surgery       Date:  2020-08-15       Impact factor: 3.982

8.  Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients.

Authors:  Lina Zhang; Changying Xing; Chong Shen; Ming Zeng; Guang Yang; Huijuan Mao; Bo Zhang; Xiangbao Yu; Yiyao Cui; Bin Sun; Chun Ouyang; Yifei Ge; Yao Jiang; Caixia Yin; Xiaoming Zha; Ningning Wang
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

9.  Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism.

Authors:  Woo Young Kim; Jae Bok Lee; Hoon Yub Kim
Journal:  J Korean Surg Soc       Date:  2012-06-26

10.  Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism.

Authors:  Monique Nakayama Ohe; Rodrigo Oliveira Santos; Ilda Sizue Kunii; Aluizio Barbosa Carvalho; Márcio Abrahão; Murilo Catafesta das Neves; Marise Lazaretti-Castro; Onivaldo Cervantes; Jose Gilberto Henriques Vieira
Journal:  Braz J Otorhinolaryngol       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.